Enhanced Recovery After Surgery (ERAS) Improves Length of Stay and Decreases Complications After Resection of Abdominal Neuroblastoma
Topic overview
Multi-institutional study demonstrates that ERAS protocols in pediatric neuroblastoma resection reduce hospital stay from 6.9 to 3.7 days, decrease complications from 96% to 39%, and cut opioid use by 61%. Early diet advancement and ambulation are key drivers of improved outcomes in this complex surgical population.
Key takeaways
- ERAS protocol reduced post-op complications from 96% to 39% in pediatric neuroblastoma resection patients
- Length of stay decreased by 3.2 days (6.9 to 3.7 days) with ERAS implementation across three institutions
- Post-operative opioid use cut by 61% (0.54 to 0.21 MME mg/kg/day) with standardized ERAS pathway
- Nasogastric tube use dropped from 92% to 17%; patients advanced to regular diet 3 days earlier with ERAS
- Multi-institutional ERAS protocol is feasible and beneficial for complex pediatric oncologic abdominal surgery
Comments